Post-earnings recap
Reported
Mon, May 6, 2024
EPS actual
$-0.72
EPS est.
$-0.67
EPS surprise
-7.46%
1-day move
-3.32%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
The earnings report indicates that Day One Biopharma is still facing challenges, particularly reflected in their EPS miss. The stock reacted negatively, dropping 3.32%, likely due to investor concerns about profitability and the lack of revenue data. Without guidance, investors may remain uncertain about the company's future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.72 | N/A | -7.46% |
| Revenue | N/A | N/A | N/A |
Management expressed concerns about the current performance but remains focused on future developments. They did not provide specific guidance for the upcoming quarters.
Management acknowledged the challenges faced this quarter.
They emphasized a focus on long-term goals despite current setbacks.